The mucosal immune system defends the ocular surface against antigenic challenge ([@bib78]; [@bib182]; [@bib186]; [@bib172]; [@bib260]; [@bib235]. This immunologic role is mediated primarily through secretory IgA (S-IgA) antibodies, which are known to inhibit viral adhesion and internalization; prevent bacterial attachment, colonization, and activity; interfere with parasitic infestation; and reduce antigen-related damage in mucosal sites ([@bib277]; [@bib176]; [@bib41]; [@bib207]. Thus, the ocular mucosal immune system appears to protect the eye against allergic, inflammatory, and infectious disease, thereby promoting conjunctival and corneal integrity and preserving visual acuity.

This chapter reviews the immunologic architecture and regulation of the ocular mucosal immune system and explores the impact of ocular infection and autoimmune disease on this system\'s structure and function. For information on nonmucosal aspects of ocular immunity, such as anterior chamber-associated immune deviation and retinal immunology, the reader may refer to several excellent sources ([@bib146]; [@bib213]; [@bib257].

ARCHITECTURE OF OCULAR MUCOSAL DEFENSES {#cesec1}
=======================================

The epithelia of the cornea, the conjunctiva, and the lacrimal drainage system, the tear film, the lacrimal glands, and the eyelids act as a functional unit to preserve the quality of the refractive surface and protect ocular structures. These components are in anatomic continuity and share feedback mechanisms whereby simultaneous reactions occur to a single stimulus ([@bib230]).

Lacrimal gland {#cesec2}
--------------

The principal tissues involved in immunologic protection of the ocular surface are the lacrimal gland and the conjunctiva. The lacrimal gland, which serves as the predominant source of tear S-IgA antibodies, is the primary effector tissue in the eye\'s secretory immune defense ([@bib261]; [@bib215]; [@bib78]; [@bib186]; [@bib172]; [@bib260]). It is made up of acinar units consisting of secretory acinar epithelial cells, which are surrounded by myoepithelial cells and a basement membrane. The acinar units are interconnected by ductules, which drain into the glandular ducts and from there to the superotemporal conjunctival cul-de-sac ([Fig. 86.1](#f1){ref-type="fig"} ; [@bib295]. Smaller accessory lacrimal glands are also found in the upper and lower conjunctiva, which drain directly through the epithelium ([Fig. 86.2](#f2){ref-type="fig"} ; [@bib236].Fig. 86.1Schematic representation of the secretory immune system of the human lacrimal gland. Topographical features include acinar cells, which contain endoplasmic reticulum (ER) and lysozyme- and lactoferrin-positive zymogen granules (ZG), and synthesize and secrete secretory component (SC); myoepithelial cells, which are adjacent to acinar cells and surrounded by a basement membrane (BM); interstitial plasma cells, which are the primary lymphoid cell and produce principally IgA, but also some IgG, IgM or IgD; T helper (T~H~) and suppressor (T~S~) cells, which are distributed throughout the interstitium, the intercellular spaces between acinar or ductal cells, and the periductular lymphoid aggregates; B cells (B), OKT6^+^ Langerhans-type dendritic cells (DC), and OKM1^+^ monocyte-macrophages are predominantly located in periductular lymphoid aggregates, which most often appear as primary follicles without germinal center formation and may be active in antigen processing; and unlabelled, darkened cells, which refer to circulating T or B lymphocytes, which may originate in other mucosal tissues (*e.g.,* intestinal Peyer\'s patch) and, if not retained locally, possibly exit the lacrimal gland through lymphatic channels to regional cervical or preauricular lymph nodes. Immunoglobulin A is secreted by plasma cells, bound by SC on the acinar cell basolateral membrane, transported in distinct vesicles, and released at the apical surface as S-IgA into tear-containing lumina.(This figure has been reproduced and published courtesy of *Ophthalmology* 1988; 95:100--109.)© 20052005Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.Fig. 86.2Diagrammatic representation of lymphocyte populations in the "normal" human conjunctiva. The epithelium (EPI) contains T helper (T~H~) and suppressor (T~S~) cells and Langerhans-type dendritic cells (LC). The substantia propria (SP) also contains these T-cell populations, as well as non-Langerhans interdigitating cells (DC) and lymphoid aggregates harboring predominately B cells (B). Additional cell types in conjunctival tissue are mentioned in the text. The accessory lacrimal gland (gland of Krause) is analogous to the main lacrimal gland and contains a number of plasma cells (P). In this figure, the letter "G" refers to intraepithelial mucus-producing goblet cells.(This figure has been reproduced and published courtesy of *Ophthalmology* 1986; 93:1276--1283.)© 20052005Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Lacrimal glands contain a diverse array of leukocytes, including plasma cells, T cells, B cells, lymphocytes bearing the human mucosal lymphocyte-1 antigen (HML-1, beta 7 integrin), dendritic cells, macrophages, monocytes, and natural killer cells **(** [Table 86.1](#cetable1){ref-type="table"} ; [Fig. 86.1](#f1){ref-type="fig"}). In humans, plasma cells represent greater than 50% of all mononuclear cells in lacrimal tissue, the vast majority being IgA-positive with both IgA1 and IgA2 expressed. A high percentage of lacrimal IgA plasma cells synthesize J chain and produce polymeric IgA (pIgA). The pIgA binds the polyimmunoglobulin receptor (membrane insert piece + secretory component \[SC\]) produced by epithelial cells, undergoes transcytosis, and is released as secretory IgA (S-IgA), the major effector molecule in mucosal defense ([@bib79]; [@bib4]; [@bib96]; [@bib50]; [@bib10]; [@bib27]; [@bib277]; [@bib135]; [@bib176]; [@bib295]; [@bib41]. These cells are complemented by limited numbers of IgG, IgM, IgE, and IgD plasma cells ([@bib7]; [@bib28], [@bib29]).Table 86.1Lymphocyte Populations Identified in Lacrimal Glands of Various SpeciesSpeciesReferences**Human**•IgA (predominant; both IgA1 and IgA2), IgG, IgM, IgD, and IgE plasma cells•Suppressor/cytotoxic (predominant), helper, and activated (IL-2+) T cells•Surface IgM- (predominant), IgD-, IgG-, or IgA-bearing B cells•HML-1^+^ (αEβ7) lymphocytes•Macrophages, monocytes, and dendritic cells[@bib79]; [@bib7], [@bib10]); [@bib27], [@bib28], [@bib29]); [@bib96]; [@bib50]; [@bib295]; [@bib66]; [@bib87]**Rabbit**•IgA (predominant) and IgG plasma cells[@bib246]; [@bib83]; [@bib125]**Rat**^•^ IgA (predominant), IgG (IgG1, IgG2a, IgG2b, IgG2c) and IgM plasma cells^•^ Surface IgM-, IgA-, and IgG-bearing B cells^•^ Macrophages, mast cells^•^ Recent thymic emigrants, suppressor/cytotoxic, helper, primed effector, naive or memory (rare), and possibly extrathymic, T cells, αEβ7^+^ T cells, NKT cells[@bib101]; [@bib269];[@bib6]; [@bib106]; [@bib212]; [@bib183];[@bib298]; [@bib204], [@bib205]); [@bib267]**Mouse**•IgA (predominant), IgG, and IgM plasma cells•Surface IgA-, IgG-, or IgM-bearing B cells•NKT cells, B-1 cells[@bib174]; [@bib185]; [@bib237]

The second most frequent lymphocyte population in human lacrimal tissue are T cells, which are situated between acinar and ductal epithelial cells, throughout glandular interstitial regions, and within small, periductular, lymphoid aggregates. The distribution of T cells varies topographically by subclass, which include CD8^+^ suppressor/cytotoxic and CD4^+^ helper T cells, which have a helper:suppressor ratio of approximately 0.5. Minor populations of lacrimal immunocytes include surface Ig-bearing B cells, Langerhans-type dendritic cells, monocyte-macrophages, and activated, IL-2-positive T cells, which occur almost exclusively in periductular foci, appearing as primary follicles without germinal centers ([@bib295]; [@bib66]; [@bib213]. Lacrimal glands of rats, rabbits, and mice share the immune features of the human gland (see [Table 86.1](#cetable1){ref-type="table"}).

In addition to S-IgA, the lacrimal gland supplies a number of nonspecific factors to the aqueous layer of the tear film that contribute to the mucosal defense of the outer eye. Lacrimal acinar cells produce lysozyme, lactoferrin, and β-lysin, which have antibacterial properties. Lysozyme is a bacteriolytic enzyme that makes up 40% of tear protein ([@bib95]; [@bib97]. Although its existence in tears has been debated ([@bib127], the nonlysozyme factor β-lysin is also bacteriolytic ([@bib72]. Lactoferrin makes up 25% of the protein in human tears and has several functions. It enhances the function of NK cells, it deprives bacteria of iron, and it inhibits the formation of biologically active complement by inhibiting the formation of C3 convertase ([@bib12]; [@bib138]; [@bib136]; [@bib176]; [@bib33]. Lacrimal glands also produce and secrete into the tears antimicrobial peptides including defensins ([@bib112]. Many additional molecules including growth factors and cytokines related to ocular surface health are produced in the lacrimal gland and have been identified in tears. The immunologic characteristics of human accessory lacrimal tissue appear to be identical to those of the major lacrimal gland ([@bib96], [@bib97]; [@bib236]).

The migration of lymphocytes into the lacrimal gland appears to be random ([@bib174]). Yet, the selective retention and heterogenous distribution of IgA-containing or T cells within lacrimal tissue are not random and may be stimulated by antigenic challenge and regulated by microenvironmental, endocrine, neural, T-cell, and/or acinar epithelial cell signals ([@bib125]; [@bib82]; [@bib285]; [@bib6]; [@bib106]; [@bib81]; [@bib78]; [@bib85]; [@bib264], [@bib267]). The lymphocytic accumulation in, or adherence to, lacrimal tissue appears to require receptors, divalent cations, intact metabolic, oxidative phosphorylation, and contractile microfilament systems, and to depend upon cellular surface protein and carbohydrate determinants ([@bib200]; [@bib201], [@bib202], [@bib203]).

Conjunctiva {#cesec3}
-----------

The conjunctival tissue consists of an outer squamous epithelial cell layer (two to five cells thick) interspersed with goblet cells, a basement membrane, and underlying stromal connective tissue. [Figure 86.2](#f2){ref-type="fig"} ([@bib236] diagrams the major features of the human conjunctiva. The conjunctiva has been postulated to possess a system of specific immune defense in the form of mucosa-associated lymphoid tissue (MALT) ([@bib38]). MALT consists of arrangements of lymphatic cells located in and closely beneath the epithelium, which function to detect antigen and induce immune responses by the direct action of the lymphatic cells or by the secretion of soluble antibodies ([@bib144]). The presence of conjunctiva-associated lymphoid tissue (CALT) has been uncertain. In some animal species, components of MALT were described in conjunctiva, showing species-specific differences ([@bib13]; [@bib84]; [@bib152]; [@bib233]; [@bib141]; [@bib43], [@bib44]; [@bib42]). Early human studies using histochemical methods ([@bib134]; [@bib5] and more recent immunohistochemical studies analyzing small biopsy specimens ([@bib236]; [@bib66]; [@bib114] reported differing results as to number and localization of the cells, which did not clearly establish whether conjunctival lymphoid cells formed a functionally active CALT system. Recently, [@bib143] analyzed whole mounts of normal human conjunctival sacs and determined the associated lymphoid tissue contains all the components necessary for an immune response and that expression of IgA and secretory component indicates that conjunctiva belongs to the mucosal immune system. Lymphoid tissue was mainly observed in the palpebral conjunctiva, more pronounced in the upper lid than the lower. Diffuse lymphoid tissue of lymphocytes (predominantly T cells) and plasma cells (most of which were IgA^+^) formed a thin layer in the lamina propria of all the conjunctival sacs. The overlying epithelium produced secretory component. In three-fifths of the specimens, organized follicular accumulations having a lenticular shape, composed of B lymphocytes, and covered by a lymphoepithelium were embedded in the diffuse lymphoid layer. High endothelial venules were present in all types of lymphoid tissue ([@bib141], [@bib142], [@bib143]). Unlike the M cell containing follicle-associated epithelium (FAE) covering Peyer\'s patches, no differences between the appearance of microvilli of conjunctival FAE and that of nonfollicle-associated epithelium were noted by transmission electron microscopy in 13 mammalian species ([@bib44]; [@bib42]). Despite the apparent ubiquity of conjunctival lymphoid follicles in rabbits, ferrets, guinea pigs, cats, dogs, pigs, sheep, cows, rhesus monkeys, baboons, owl monkeys, bush baby monkeys, and humans, few or no lymphoid tissues were identified in mice or rats ([@bib244]; [@bib44], although MALT has recently been demonstrated in nictitating membranes of mice ([@bib238]. Similar lymphoid tissue was also observed inside the lacrimal drainage system and has been termed lacrimal drainage-associated lymphoid tissue (LDALT) ([@bib142]). The presence of organized CALT appears to be related to antigenic exposure, as evidenced by the rapid increase in conjunctival lymphoid tissue in early youth and a reduced amount under germfree conditions ([@bib175]. CALT and LDALT appear to be regularly present and to belong to the common mucosal immune system and to the secretory immune system. Together with the lacrimal gland, they may form a functional unit connected by tear flow, lymphocyte migration, and probably the neural reflex arc, and play a major role in preserving ocular surface integrity ([@bib143]; [@bib230]; [@bib142]). In addition, the conjunctiva contains the immunologic capacity for antigen processing, cell-mediated immunity, and hypersensitivity responses ([@bib3]; [@bib38]; [@bib107]; [@bib236]; [@bib46]; [@bib1]; [@bib186]).

Cornea {#cesec4}
------

Although the conjunctiva and the cornea are similarly exposed to the outside environment, the defensive mechanisms of the two tissues are fundamentally different. Whereas the conjunctiva is a highly reactive tissue that is protected by a potent immune system, the cornea is relatively unreactive, with the immune system repressed to some extent to avoid inflammatory reactions that could compromise the cornea\'s transparency. Defense is aided by cell polarity, tight cell junctions, and continual replacement of the epithelium. The epithelium produces very high levels of membrane-bound complement inhibitors, PAI-2, and has the ability to produce alpha2-macroglobulin and alpha1-antiproteinase, thereby reducing the risk of autologous cell damage ([@bib235]. The cornea also produces very high levels of antioxidants ([@bib231] that may protect the ocular surface from reactive oxygen species produced by activated PMN cells. The cornea possesses interstitial IgA, IgG, IgM, IgD, and IgE, which appear to originate from serum, diffuse from the limbal to central regions, and require extended time periods (*e.g.,* months) for complete turnover ([@bib9]; [@bib281]; [@bib219]. SC is not produced by the "normal" avascular corneal epithelium or stroma ([@bib4]). The peripheral cornea, which is in close contact to the conjunctival vasculature, may also contain Langerhans cells and macrophages ([@bib219]. Although early studies determined that lymphocytes and differentiated Langerhans cells are essentially absent from the normal central cornea ([@bib5]; [@bib243], recent studies using immunohistochemical confocal microscopic analyses of rodent corneal whole mounts have demonstrated the presence of small numbers of CD3^+^ T cells (both CD4^+^ and CD8^+^), macrophages, and dendritic cells (Langerhans cells), but no B cells, in the peripheral cornea and limbus ([@bib302]. In addition to these peripheral cells, a novel MHC class II-negative population of resident corneal Langerhans-type dendritic cells has been identified in the central cornea ([@bib105]. The corneal stroma is endowed with at least three bone marrow--derived dendritic cell subsets ([@bib104] as well as a novel macrophage population ([@bib31]. In inflammation these dendritic cells become activated, as evidenced by expression of B7 costimulatory markers, and following corneal transplantation, express MHC class II and migrate to the draining lymph nodes ([@bib159]; [@bib104]. These findings refute the tenet that the cornea is immune privileged because of lack of resident lymphoreticular cells or because of antigenic sequestration from systemic immunity. Membrane-bound or soluble chemotactic factors, locally produced in the periphery, prevent Langerhans cell migration from the limbus unless a stronger stimulus (*e.g.,* IL-1) is produced. IL-1β is secreted by corneal epithelial cells in response to IFNγ or bacterial infection ([@bib283]). Further, normal keratocytes express MHC class II molecules in response to inflammation, suggesting that keratocytes collaborate with APC in antigen presentation to T cells, leading to activation of the humoral response, cell-mediated immunity, and inflammation ([@bib194]). During inflammation, macrophages and neutrophils extravasate from the vasculature and generate cytokines including TGF-β IL-1, IL-6, and TNF-β that facilitate T-cell and B-cell differentiation and activation. Cytokines produced by immune cells and keratocytes exacerbate the inflammatory response, complement-mediated cytotoxicity, and angiogenesis. To counter the cytotoxic damage that may ensue from inflammation, the cornea protects itself by producing TGF-β which suppresses cell-mediated immune responses, and Fas-L, which prevents cell-mediated damage to the epithelial cells ([@bib235].

Tear film {#cesec5}
---------

The preocular tear film plays a critical role in the eye\'s defense against microbial and antigenic exposure, as well as in the maintenance of corneal clarity and visual ability ([@bib115]; [@bib155]; [@bib154]; [@bib230]). These functions are extremely dependent upon the stability, tonicity, and composition of the tear film structure, the actual architecture of which is not totally resolved. Classically, the tear film has been considered to include an underlying mucin foundation, a middle aqueous component, and an overlying lipid layer ([@bib115]; [@bib292]; [@bib56]). Recently, a two-layered structure with an underlying aqueous-mucin gel, in which the mucins have a decreasing gradient of concentration from the epithelium to the surface, and an overlying lipid layer, has been proposed ([@bib64]). The thickness of the tear film is also under discussion ([@bib230]). There is evidence that the mucous layer of the film could be as thick as 30 μm, but a thinner film has also been hypothesized. Recent evidence suggests a 3 μm thickness for the tear film ([@bib140]. Alteration, deficiency, or loss of the tear film may significantly increase the susceptibility to ocular surface desiccation and infection, corneal ulceration and perforation, and marked visual impairment and blindness ([@bib150]; [@bib292]; [@bib160]; [@bib155]; [@bib154]).

### The mucous layer and IgA {#cesec6}

The largest part of the mucinous content of the tear film is produced by conjunctival goblet and epithelial cells, and closely adheres to the surface of the globe. The major mucin species is MUC5AC, present in a variety of molecular sizes and glycoforms ([@bib98]; [@bib130]. The corneal and conjunctival epithelial cells produce a mucinlike glycoprotein (MUC1) at the apical surfaces that constitutes a glycocalyx, which binds loosely to the mucin layer ([@bib98]). This transmembrane mucin facilitates tear film spreading and ocular surface wetting and prevents adherence of foreign debris, cells, or pathogens to the ocular surface. The mucins account for the viscoelastic properties of the tear film, maintaining the dioptic integrity in the interblink period, and minimize the trauma to the ocular surface during blinking ([@bib63]; [@bib272]). There is evidence that S-IgA and small, basically charged tear proteins such as lysozyme accumulate in the ocular mucin layer ([@bib39]; [@bib26].

Specific immunity at the ocular surface is mediated primarily through the action of IgA antibodies, which are the predominant immunoglobulin in tears of humans and experimental animals, occur almost entirely in polymeric form, and originate primarily from local production in lacrimal gland plasma cells ([@bib40]; [@bib128]; [@bib261]; [@bib215]). In humans, tear IgA is distributed almost equally among IgA1 and IgA2 subclasses ([@bib60]. Most tear IgA appears to be bound to, and transported by, SC, which is synthesized and secreted by lacrimal epithelial cells ([@bib79]; [@bib96]; [@bib101]; [@bib109], [@bib108]; [@bib133]; [@bib267] and is present in the tear film as an S-IgA conjugate or as free SC. In addition, although tear Ig levels do not appear to display diurnal rhythms, IgA concentrations may be exceedingly high after prolonged closure of the eyelids ([@bib234], [@bib235]). S-IgA has significant function in antigen-antibody clearance from the tear film. S-IgA or free SC can agglutinate antigen-IgG complexes (Sack *et al.,* 2002). Further, PMN cells have an S-IgA receptor and it appears that S-IgA can opsonize bacteria for PMN cell processing ([@bib248]; [@bib196]). S-IgA can also stimulate effector functions in eosinophils ([@bib188]). Antigen-IgA complexes will not ordinarily activate complement, and, therefore, S-IgA is considered anti-inflammatory in nature ([@bib197]. The role of S-IgA may not be essential in antimicrobial defense because an SC knockout mouse does not exhibit a greater frequency of serious ocular or other mucosal infections ([@bib129]. However, lack of J chain inhibits transepithelial transport of IgA and abrogates the development of intestinal antitoxic protection in knockout mice ([@bib162].

### Aqueous layer {#cesec7}

Nearly 500 proteins have been identified in normal human tear fluid, including mucins, growth factors, tissue maintenance factors, and antimicrobial agents, the nature of which suggest contributions from serum exudate, lacrimal and accessory gland secretions, ocular surface components, and secreted products of PMN cells ([@bib89]. The major sources of the tear aqueous layer are lacrimal and accessory gland secretions. These secretions are derived from two independent processes: a slow constitutive ongoing secretion, consisting of almost exclusively secretory IgA and smaller amounts of free SC, and an inducible neurologically controlled lacrimal secretion. Although complex, the inducible lacrimal secretion consists of predominantly three proteins---lysozyme, lactoferrin, and tear-specific lipocalins, each of which exhibits anti-inflammatory and antimicrobial properties ([@bib235].

Lactoferrin represents 21% of the total reflex tear protein. The anti-inflammatory and antimicrobial functions of lactoferrin are attributed to its capacity to bind divalent cations and numerous ligands, as well as its basically charged peptide sequence near the N-terminus. Lactoferrin inhibits complement activation, decreases the capacity of PMN cells to release oxygen radical species, and chelates iron, thereby depriving many bacteria of a necessary nutrient. Lactoferrin destabilizes the cell wall of gram-negative bacteria by its chelation actions. The cationic detergent function of the highly basic N-terminal sequence (lactoferricin) disrupts the cell membrane of some gram-negative bacteria (*e.g., Pseudomonas, E. coli, Proteus*), *Staphylococcus aureus,* yeast, and filamentous fungi, as well as some viruses including HIV and HCMV ([@bib137]; [@bib234], [@bib235]).

Lysozyme represents ∼33% of the reflex tear proteins. This enzyme cleaves the polysaccharide backbone of the murein layer of the bacterial cell wall as well as chitin in the fungal cell wall. Further, lysozyme can inhibit HIV transmission and inhibits complement activation ([@bib172]; [@bib234], [@bib235]).

Tear-specific lipocalins (TSL), which represent ∼25% of the reflex tear proteins, contain a putative functional cystatin-like protease inhibitory domain that has been suggested to protect the ocular surfaces from microbe-derived cysteine proteases. Other properties of TSL are consistent with an ocular defense function. Tear proteins, including lactoferrin, lysozyme, and S-IgA, complex with TSL. A lipid-binding domain allows TSL to transport lipids (*e.g.,* retinol) essential for maintenance of goblet and epithelial cell integrity. This domain may also allow the removal or sequestration of toxic lipids such as endotoxin ([@bib99]. Further, TSLs convert hydrophobic surfaces to hydrophilic ones, a property that may be useful in clearing hydrophobic foreign objects from the ocular surface and which affects tear surface tension ([@bib90]; [@bib234], [@bib235]).

When the rate of reflex tear secretion decreases, the constitutively secreted S-IgA becomes the fourth major protein constituent. In addition, the open eye tear fluid contains numerous other proteins that have anti-inflammatory and antimicrobial properties, including specific leukocyte protease inhibitor, elafin, and pro- and active members of the α and β defensin families. Other antimicrobial agents detected in the open eye tear fluid include β-lysin, TFF peptides, CAP-37, CAP-38, phospholipase A2, and PMN cell defensins and elastase. Also, antiproteases, various cytokines, vitronectin and neutrophil gelatinase-specific lipocalin have been detected. The reader is referred to [@bib235] for an excellent review.

Overnight eye closure is associated with an increase in S-IgA, vitronectin, elastase, α1-antitrypsin, specific leukocyte protease inhibitor, fibronectin, and albumin levels; the appearance of complement components C1q, C3, factor B, C4, C5, and C9; the conversion of complement C3 to C3c; plasminogen activation; and the recruitment of PMN cells into the tear film, as well as an enhanced incidence of gram-positive bacteria in the conjunctival sac ([@bib234], [@bib235]).

### Lipid layer {#cesec8}

The principal role of the outer lipid layer is to prevent evaporation of the tears and enhance the stability of the tear film, thereby indirectly contributing to the antimicrobial nature of the tear film ([@bib235]; [@bib230]). It consists of a variety of lipid constituents, including waxy esters, triglycerides, free fatty acids, and polar lipids secreted by meibomian glands located within the tarsal plates ([@bib173]).

Other defense mechanisms {#cesec9}
------------------------

Other tissues, organisms, and factors involved in nonspecific mucosal defense of the eye include the (1) orbital skeletal structure, which minimizes potential trauma; (2) eyelid architecture, which is relatively impermeable to macromolecules; (3) eyelid blink reflex and ciliary movement, which rapidly clear foreign objects from the ocular surface; and (4) continuous tear flow and reflex tearing, which act to remove microorganisms and cellular debris through hydrokinetics and eventual drainage into the nasolacrimal duct ([@bib250]). In addition, the presence of resident conjunctival populations of nonpathogenic bacteria, consisting of aerobes and facultative and obligate anaerobes, may curtail the ability of invasive bacteria to attach and colonize. The normal flora depletes the tear fluid of nutrients, reacts with binding sites that might otherwise be available for pathogens, and secretes bacteriocidins that make the environment less hospitable for the growth of potential pathogens ([@bib235].

INDUCTION OF OCULAR MUCOSAL IMMUNITY {#cesec10}
====================================

Mucosal immunity constitutes an important first line of defense that protects the surfaces of the aerodigestive and urogenital tracts, as well as the ocular surface. The various mucosal effector sites are linked by migrating lymphocytes, which give rise to IgA antibody-producing cells. The major features of the mucosal immune network, including the relevance of the mucosal system in immune defense, are detailed in a number of publications ([@bib176]; [@bib41], including this volume. The conjunctiva, lacrimal drainage apparatus, and the lacrimal glands fulfill the criteria for inclusion in the common mucosal immune system. As detailed previously, conjunctiva-associated lymphoid tissue (CALT) in humans and many species functions as an antigen-sampling and, along with its draining lymph nodes, an immune inductive tissue. Also, the conjunctiva may serve as a mucosal immune effector site ([@bib84]; [@bib78]; [@bib141], [@bib143]). The nasal-associated lymphoid tissue (NALT) also receives antigen after application to the conjunctival sac ([@bib35]; [@bib227]. In contrast, the lacrimal gland functions as a mucosal effector tissue, receiving antigen-stimulated, IgA-committed B cells after antigen stimulation in the intestinal Peyer\'s patches or other mucosal inductive sites ([@bib82]. It contains IgA-secreting plasma cells, which are responsible for the majority of S-IgA released into the tear fluid.

Response to defined antigens {#cesec11}
----------------------------

Antigenic challenge to the surface of the eye may result in a marked accumulation of specific S-IgA, IgG, and IgM antibodies in tears; an accelerated and enhanced anamnestic response after secondary exposure; and the generation of immune resistance to, and protection against, antigen reexposure ([@bib177]. In addition, definitive ocular immune responses, as well as accumulation of Ig-containing cells in lacrimal tissue ([@bib125]; [@bib6], may be stimulated by antigenic challenge to other sites, including subconjunctival, intra-corneal, intravitreal, intranasal, oral, intrabronchial, gastric, intraduodenal, intravenous, subcutaneous, intradermal, or intramuscular routes. The nature (*e.g.,* antibody isotype), extent, and kinetics of these immune reactions appear to be dependent upon the form (*e.g.,* live versus inactivated microorganisms; strain), concentration, route, duration, and frequency of antigen administration. Potential immune responses may be augmented, intermittent, suppressed, or absent, as reviewed in [@bib186]. Moreover, the magnitude of induced ocular immunity may be altered by the use of adjuvants ([@bib214]; [@bib216]), cytokines ([@bib222]; [@bib223], immunostimulatory DNA ([@bib94]), and microspheres ([@bib223]; [@bib227] and influenced by the concurrent state of systemic immunity ([@bib286]).

The mechanism by which antigenic exposure to the surface of the eye stimulates a local immune (*e.g.,* IgA) response remains to be elucidated. Direct antigen transfer across the conjunctival epithelium or countercurrent passage through the lacrimal duct appears to be severely restricted ([@bib119]; [@bib132]; [@bib267]. Furthermore, the immunologic architecture of healthy lacrimal tissue appears to limit its capacity to effectively process and present antigen ([@bib295]. With respect to conjunctival tissue, its role remains unclear. Consequently, it is possible that the ocular secretory immune response to infectious or toxic substances may require antigenic clearance through the nasolacrimal duct and stimulation of intranasal and gut-associated lymphoid tissue. Consistent with this hypothesis are the following observations: (1) topical application of noninvasive antigens to the rat ocular surface appears to result in passage through the nasolacrimal canal into the gastrointestinal tract, and not retrograde transfer to the lacrimal gland or lymphatic drainage into local lymph nodes ([@bib267]. Similarly, herpes simplex virus in human tears has been shown to flow through the lacrimal canaliculi into the nasal cavity ([@bib303]); (2) intranasal, oral, or gastric administration of bacteria, viruses, or other antigens may induce the accumulation of specific tear IgA antibodies and the generation of ocular surface protection ([@bib177]; [@bib193]; [@bib180], [@bib181], [@bib184]; [@bib20]; [@bib286]; [@bib52]; [@bib280]; [@bib214]; [@bib216]; [@bib58]; [@bib35]; [@bib199]; [@bib179]; [@bib227]; [@bib94]).

Remote-site stimulation would most likely involve IgA lymphoblast migration from nasal- or gastrointestinal-associated lymphoid tissue, and from cervical or mesenteric lymph nodes, via the thoracic duct lymph, to the lacrimal gland ([@bib180]; [@bib174]; [@bib185]; [@bib200]; [@bib186]), followed by local antibody production and transport to the ocular surface. In contrast, the contribution of serum IgA antibodies to ocular surface defense appears to be minimal or nonexistent ([@bib261]; [@bib184]; [@bib20]; [@bib215]; [@bib52]. IgG antibodies from serum, though, may serve a significant role in certain inflammatory disorders of the eye ([@bib102]; [@bib163]; [@bib297]. Overall, ocular immune protection may be conferred by both local and distant antigenic exposure, with lacrimal tissue acting as a recipient of committed IgA-containing cells that elaborate antigen-specific antibodies. However, the development of an optimal strategy to promote secretory immunity in the eye has yet to be established.

Influence of ocular or systemic disease and contact lens wear {#cesec12}
-------------------------------------------------------------

Various ocular and systemic diseases, as well as contact lens wear, may significantly influence secretory immune expression in the human eye. Bacterial, viral, and fungal infections of the ocular surface, exposure to allergens, endocrine abnormalities, or graft versus host disorders may significantly increase levels of specific antibodies, total immunoglobulins, complement proteins, and nonspecific immune factors or induce changes in the lymphocytic profile of the conjunctiva. Of interest, if pathologic alterations are evident in only one eye, immune responses may ([@bib245] or may not ([@bib37] occur in the contralateral, unaffected eye. With regard to contact lenses, these may bind ([@bib101], and also cause modifications in the concentration of immune components in the tear film. The precise immunologic effects may depend upon the composition of lens material, the efficacy of cleaning regimens, and/or the length of wear ([@bib167]; [@bib282].

In contrast, such conditions as IgA deficiency, ocular surgery, keratoconjunctivitis sicca, malnutrition, or autoimmune disease may often suppress ocular mucosal immunity. Thus, for example, pigmentary keratitis has been linked to tear S-IgA insufficiency ([@bib88], and severe malnutrition may lead to a significant decrease in tear IgA and SC concentrations, a diminished number of IgA-containing cells in lacrimal tissue, and a blunted S-IgA antibody response to infectious challenge ([@bib288]; [@bib265]. Similarly, autoimmune disorders such as multiple sclerosis or Sjögren\'s syndrome may significantly alter or disrupt immune function in the eye. Multiple sclerosis, an autoimmune disease of possible viral origin, is associated with heightened levels of monomeric IgA and lymphocytes and reduced amounts of SC in tears of afflicted individuals ([@bib49]). Sjögren\'s syndrome, an autoimmune disease that occurs almost exclusively in females, is characterized by a progressive lymphocytic infiltration into the lacrimal gland, an immune-mediated destruction of lacrimal acinar and ductal epithelial cells, decreased tear IgA content, and keratoconjunctivitis sicca ([@bib189]; [@bib139]; [@bib116]; [@bib258]). Furthermore, in experimental models of this complex disorder, the generation of autoantibodies ([@bib208] and autoreactive T cells to ([@bib274], and the deposition of IgG, IgA, and complement in ductal epithelial cells of ([@bib61], lacrimal tissue may accompany the striking glandular inflammation ([@bib122]; [@bib123]; [@bib274]; [@bib270]; [@bib266]; [@bib228]; [@bib278]). The etiology of Sjögren\'s syndrome may involve the endocrine system ([@bib11]; [@bib271]; [@bib191]; [@bib2]; [@bib118]; [@bib117]; [@bib258], [@bib259]; [@bib266], [@bib260]) but may also be due to primary infection by, and reactivation of, Epstein-Barr virus (EBV), cytomegalovirus (CMV), herpes virus-6, hepatitis C, or retroviruses ([@bib32]; [@bib73]; [@bib100]; [@bib145]; [@bib169]; [@bib75]; [@bib218]; [@bib170]; [@bib213]. These viruses have been identified in lacrimal and/or salivary tissues of Sjögren\'s patients ([@bib32]; [@bib76]; [@bib73]; [@bib145]; [@bib93]; [@bib169]; [@bib218]; [@bib275]; [@bib213] and may possibly stimulate the inappropriate, epithelial cell HLA-DR expression, T helper/inducer cell activation, B-cell hyperactivity, and autoantibody production evident in these affected tissues ([@bib189]; [@bib166]; [@bib73]; [@bib116]. In support of this possibility, certain viral infections in experimental animals exert a striking impact on the lacrimal gland and induce a periductular infiltration of plasma cells, lymphocytes and macrophages, distinct nonsuppurative periductular inflammation, significant interstitial edema, widespread necrosis of the acinar and ductal epithelium, degenerative and atrophic alterations in epithelial cells, diminished tear flow, and keratoconjunctivitis sicca ([@bib126]; [@bib100]. Moreover, recent research has demonstrated that herpes viruses (*i.e.,* cytomegalovirus) and coronaviruses (*i.e.,* sialodacryoadenitis virus) may invade and replicate in rat lacrimal gland acinar cells ([@bib120]; [@bib293], EBV may bind to specific receptors in ductal epithelium of the human lacrimal gland ([@bib156], and human immunodeficiency virus infection may predispose patients to keratoconjunctivitis sicca ([@bib48]; [@bib276]; [@bib59]; [@bib161]; [@bib192]. However, the precise role of viruses in the induction of autoimmune disease, as well as the mechanism by which viral infection may interfere with lacrimal gland function and immune expression, remains to be determined.

Neuroendocrine modulation {#cesec13}
-------------------------

For many years it has been recognized that the endocrine and nervous systems regulate multiple aspects of cellular and humoral immunity. This hormonal and neural control, which significantly influences such parameters as lymphocyte differentiation and maturation, antigen presentation, cytokine production, cell migration, and antibody synthesis, is regulated by two major mechanisms: (1) the hormonal stress response and the production of glucocorticoids, and (2) the autonomic nervous system with the release of noradrenalin ([@bib289]. The central nervous system can also regulate the immune system locally via the release of neuropeptides from peripheral nerves and by locally produced corticotrophin-releasing hormone ([@bib157]; [@bib68]. Moreover, this neuroendocrine-immune interrelationship is bidirectional, and antigenic exposure may also induce the lymphocytic secretion of cytokines, hormones, and neuropeptides that directly modulate endocrine and neural function ([@bib190]; [@bib22]). In fact, it has been proposed that the immune system serves as a sensory organ, providing input to the endocrine and nervous compartments in response to noncognitive stimuli, such as infection ([@bib24]). Consequently, an extensive, triangular association appears to exist between the endocrine, nervous, and immune systems that acts to promote and maintain homeostasis ([@bib17]; [@bib217]; [@bib70]; [@bib289].

In the mucosal immune system, diverse hormones and neural agonists may significantly modify the (1) accumulation, proliferation, retention and/or function of IgA- and IgG-positive cells, T cells, mast cells, eosinophils, basophils, natural killer cells, polymorphonuclear leukocytes, and/or macrophages; (2) synthesis, appearance, and/or secretion of IgA and IgG antibodies, growth factors, cytokines, adhesion molecules, apoptotic factors, the expression of MHC Class II antigens, the elaboration and release of SC, and the uptake and transport of pIgA into luminal secretions; and (3) adherence and presentation of microorganisms to mucosal cells, the magnitude of neurogenic inflammation, and the extent of local immune protection against infectious agents. In addition, antigen-induced immune responses may significantly alter mucosal neuroendocrine structure, sensitivity, and/or function ([@bib253]; [@bib290]; [@bib254]; [@bib23]; [@bib300]; [@bib301]; [@bib149]; [@bib91]; [@bib263]; [@bib259]; [@bib267]; [@bib17].

With regard to the ocular mucosal immune system, endocrine (androgens, but not estrogens or stress hormones) and neural factors appear to exert a dramatic impact on immunologic expression and activity. However, although this neuroendocrine-immune interrelationship has been definitively shown in eyes of experimental animals, it has yet to be evaluated in humans. In rats, androgens elicit a marked increase in the production and secretion of SC by lacrimal gland acinar cells ([@bib108]; [@bib133]; [@bib149]; [@bib267], enhance the concentration of IgA in lacrimal tissue ([@bib267], and stimulate the transfer and accumulation of SC and IgA, but not IgG, in tears ([@bib263]; [@bib267]. These hormone actions, which may be induced by various androgenic compounds ([@bib267], are not duplicated by estrogen, progestin, glucocorticoid, or mineralocorticoid treatment ([@bib263]; [@bib267]. Moreover, the immunologic effects of androgens appear to be unique to the eye, because androgen administration does not seem to influence IgA or SC levels in salivary, respiratory, intestinal, uterine, or bladder tissues ([@bib267] and actually suppresses mucosal immunity in the mammary gland ([@bib291]. The mechanism by which androgens regulate ocular SC dynamics may well involve hormone association with specific nuclear receptors in lacrimal gland acinar cells, binding of these androgen/receptor complexes to genomic acceptor sites, and the promotion of SC mRNA transcription and translation. In support of this hypothesis, saturable, high-affinity and androgen-specific receptors, which adhere to DNA, have been identified in lacrimal tissue ([@bib209]; [@bib267]. In addition, androgens increase SC mRNA levels in lacrimal glands ([@bib91]. Androgen-induced SC production by acinar cells may be inhibited by androgen receptor (cyproterone acetate), transcription (actinomycin D), or translation (cycloheximide) antagonists ([@bib149]. In contrast, the processes underlying androgen action on IgA in the rat eye, as well as this hormone\'s enhancement of tear IgA levels in the mouse ([@bib263]), remain to be determined.

Androgen activity may also explain the pronounced, sex-related differences in the rat ocular secretory immune system. Thus, the number of IgA-containing cells, and the IgA and SC output, are significantly greater in adult male lacrimal tissue, as compared with that of adult females. This sexual dimorphism also extends to tears, wherein from puberty to senescence, free SC and IgA, but not IgG, occur in considerably higher levels in male rats ([@bib262]; [@bib267]. Indeed, androgen influence may well be involved in the distinct sex-associated differences in the structural appearance, histochemistry, biochemistry, immunology, and molecular biologic expression of the lacrimal gland in a variety of species, including mice, hamsters, guinea pigs, rats, rabbits, and humans ([@bib287]; [@bib36]; [@bib103]; [@bib153]; [@bib47]; [@bib51]; [@bib262]; [@bib106]; [@bib211]; [@bib178]; [@bib15]; [@bib91]; [@bib266]; Toda *et al.,* 1997; [@bib229]; [@bib267]; [@bib168]; [@bib164]; [@bib226]; [@bib158]. With respect to humans, sex appears to influence the (1) degree of lymphocyte accumulation in the lacrimal gland ([@bib287]); (2) IgA concentrations in tears of adults ([@bib242], but not the elderly ([@bib239]; (3) the levels of TGF-α and EGF in tears ([@bib279]; [@bib16]; and (4) frequency of Sjögren\'s syndrome-related lacrimal gland immunopathology ([@bib189]; [@bib139]; [@bib74]; [@bib116]; [@bib266], [@bib260]). Of interest, androgen administration to animal models of Sjögren\'s syndrome (*i.e.,* MRL/Mp-lpr/lpr and NZB/NZW F1 female mice) dramatically suppresses the inflammation in, and significantly stimulates the functional activity (*e.g.,* IgA output) of, lacrimal tissue ([@bib263]; [@bib266], [@bib267]). This hormone effect appears to be tissue specific and mediated through a hormone interaction with receptors in epithelial cell nuclei causing altered expression and/or activity of cytokines, proto-oncogenes, and apoptotic factors (*i.e.,* TGF-β1, IL-1β, TNF-α, c-myb, bcl-2, and Bax) in the lacrimal gland ([@bib294]; [@bib266]; Toda *et al.,* 1997; [@bib229].

In addition to androgens, the hypothalamic-pituitary axis appears to play an important role in the expression of the rat ocular secretory immune system. Disruption of this axis by hypophysectomy or extirpation of the anterior pituitary significantly reduces the number of IgA plasma cells in lacrimal tissue, diminishes the acinar cell production of SC, causes a striking decrease in the levels of tear IgA and SC, and almost completely curtails androgen action on ocular mucosal immunity ([@bib91]; [@bib267]. Moreover, this endocrine disturbance has a marked effect on lacrimal gland structure and function, leading to glandular atrophy, acinar cell contraction, nuclear pycnosis, cytoplasmic vacuolar metamorphosis, a decrease in tissue protein and mRNA content, and a decline in fluid and protein secretion ([@bib14]; [@bib267]. The physiologic mechanisms responsible for hypothalamic-pituitary involvement in the ocular secretory immune system remain to be elucidated, but may include numerous neuroendocrine and immunologic pathways: the hypothalamus and pituitary regulate multiple endocrine circuits, directly influence neural innervation in the lacrimal gland, and clearly modulate immune activity ([@bib18]; [@bib19]). Furthermore, the hypothalamic-pituitary axis is known to control many hormones, neurotransmitters, and cytokines that modify androgen and acinar cell function and control mucosal immunity ([@bib187]; [@bib267]. Other studies in humans or experimental animals demonstrated that (1) sex steroids may significantly alter the development of allergic conjunctivitis in rabbits ([@bib240]); (2) diabetes may enhance the incidence of keratoconjunctivitis sicca ([@bib225] and significantly diminish the expression of the secretory immune system of the eye, most likely related to the absence of insulin ([@bib124]; [@bib108]; [@bib267]; and (3) both the thyroid and adrenal glands are essential to achieve the full magnitude of androgen-induced effects on the secretory immune system of the eye ([@bib267].

With respect to neural regulation of ocular mucosal immunity, the stromal, periductal, perivascular, and/or acinar areas of lacrimal tissue are innervated by many parasympathetic, sympathetic, and peptidergic fibers that harbor numerous immunoactive transmitters, including vasoactive intestinal peptide (VIP), substance P, neuropeptide pituitary adenylate cyclase-activating peptide, methionine enkephalin, leucine enkephalin, calcitonin gene-related peptide, neuropeptide Y, dopamine, 5-hydroxytryptamine, and adrenergic and cholinergic agents ([@bib232]; [@bib195]; [@bib284]; [@bib56]; [@bib298]; [@bib241]. These neural agonists are known to control lymphocyte retention and/or function in other mucosal sites ([@bib210]; [@bib285]; [@bib252]; [@bib86]; [@bib110]; [@bib53]; [@bib23]; [@bib117]; [@bib45]; [@bib296]; [@bib21]), and their release may well influence the adherence, distribution, or activity of IgA plasma cells, T cells, or mast cells in the lacrimal gland ([@bib81]; [@bib206]; [@bib80]; [@bib298]. Consistent with this possibility, VIP appears to augment T-cell attachment to murine lacrimal tissue ([@bib206], and systemic administration of the β-adrenergic blocker, practolol, suppresses human tear IgA levels ([@bib92]). However, the nature of the sympathetic-immune interaction requires further clarification because ocular application of the β-blocker, timolol, to humans, and sympathetic denervation in rats ([@bib264] had no apparent effect on tear IgA content.

More recently, it has been demonstrated that VIP and the β-adrenergic agent, isoproterenol, increase basal- and androgen-stimulated SC production by rat acinar epithelial cells ([@bib133]; [@bib149]. This neural regulation of SC synthesis may be mediated through the modulation of intracellular adenylate cyclase and cAMP activity. In support of this hypothesis, VIP and adrenergic agents are known to enhance the generation of cellular cyclic AMP ([@bib171]; [@bib55], [@bib56]). Furthermore, exposure of lacrimal gland acinar cells to cyclic AMP analogues, cyclic AMP inducers (*i.e.,* PGE~2~ and cholera toxin), or phosphodiesterase inhibitors may elevate SC production ([@bib133]. This cAMP influence on SC elaboration, although pronounced in the lacrimal gland, is not necessarily reproduced in other mucosal epithelial cells ([@bib149]. Of interest, cAMP and cGMP both appear to increase S-IgA output by human main and accessory lacrimal glands *in vitro* ([@bib121]. The mechanism underlying this cGMP action, though, is unclear, given that this compound has no effect on SC production by rat lacrimal gland acinar cells ([@bib133].

Cholinergic agonists also modulate the ocular secretory immune system. In humans, parasympathetic agents stimulate the secretion of EGF and TGF-β1 from the lacrimal gland ([@bib304], [@bib305]), whereas in birds, carbachol, by apparently binding to muscarinic acetylcholine receptors on IgG plasma cells, increases IgG output from the Harderian gland ([@bib30]; [@bib34]. In contrast, carbamyl choline acutely (*i.e.,* hours) enhances, but chronically (*i.e.,* days) decreases, basal-, cholera toxin-, and androgen-induced SC production by rat lacrimal gland acinar epithelial cells ([@bib133]; [@bib149]. The transient effect of this compound may be mediated through the mobilization of intracellular calcium, the activation of protein kinase C, and the rapid enhancement of cellular secretion ([@bib55]; [@bib149]. The processes underlying the long-term inhibitory action of carbachol, which may be prevented by atropine, is unknown, but may involve the suppression of cAMP ([@bib131] or an alteration of gene activity ([@bib149].

Neural pathways also are of importance in the spread of herpes virus infection in the eye ([@bib247], and ocular viral transmission and activity may be modulated by neuropeptides ([@bib113]. Moreover, although the optic nerve does not appear to regulate the ocular secretory immune system ([@bib264], light does seem to control anterior chamber--associated immune deviation ([@bib71], herpes virus--related retinitis ([@bib111], and various parameters of systemic immunity ([@bib165].

The mucosal immune system of the eye in experimental animals may also be regulated by cytokines. For example, IL-1α, IL-1β, and TNF-α, but not IL-6 or IFNγ, stimulate the acinar cell synthesis and secretion of SC ([@bib133]. The regulatory effect of TNF-α on acinar cell SC is similar to that found in colonic cell lines, wherein TNF-α, IFNγ, and IL-1 increase the production, surface expression, and release of SC ([@bib147]. However, the absence of IFNγ activity on SC output by acinar cells is notable, in that this cytokine regulates SC dynamics in both intestinal ([@bib251]; [@bib147]; [@bib198]; [@bib25] and uterine ([@bib300]) epithelial cells and may influence lacrimal gland acinar cell secretion ([@bib148]). Although IL-6 appears to have no influence on lacrimal SC production ([@bib133], both IL-6 and IL-5 stimulate the synthesis of IgA in lacrimal tissue explants ([@bib221]) and in combination augment the secondary tear IgA antibody response to pneumococcal antigen ([@bib222]) and suppress IgG and IgM synthesis in lacrimal tissue ([@bib220]). Similarly, TGF-β enhances IgA output from rat lacrimal tissue, whether alone or in combination with IL-2, IL-5, IL-6, or IL-5 plus IL-6 ([@bib224]). However, TGF-β or IL-4 also inhibit lymphocyte binding to lacrimal gland acinar epithelium ([@bib69].

As a further consideration, androgens, VIP, and IL-1 all share the capacity to increase IgA production in specific tissues ([@bib65]; [@bib252]; [@bib267], and pIgA, in turn, may heighten the monocytic output of TNF-α ([@bib62]. If analogous activity occurs in the lacrimal gland, then various neuroimmunoendocrine factors may control the synthesis of both IgA antibodies and the IgA receptor, leading to enhanced antibody transfer to tears and improved ocular surface defense.

OVERVIEW {#cesec14}
========

In ocular mucosal immunity, the lacrimal gland is the principal effector site where secretory IgA antibodies are produced. These antibodies are transported, via the tears, to the ocular surface where they contribute to protection against allergic, inflammatory, or infectious disease and thus promote corneal and conjunctival health. NALT (the rodent equivalent of human Waldeyer\'s ring tissue) and its draining posterior cervical lymph node (pCLN) acquire antigen and appear to function as a major inductive site for eliciting tear IgA responses following antigenic challenge to the external ocular compartments. It is thought that nonpenetrating antigen drains from the ocular surface via the nasolacrimal duct and is taken up by the M cells overlaying NALT. Alternately, antigen taken up by the conjunctiva is transported directly to the superficial (s) CLN, thus following an alternate inductive pathway that bypasses the NALT and pCLN (summarized in [Fig. 86.3](#f3){ref-type="fig"} ).Fig. 86.3Schematic summarizing the ocular mucosal immune system and control of lacrimal gland function. Exogenous (microbe-derived) or endogenous (tissue-derived) stimulatory signals from antigen-challenged mucosal surfaces may be directed to sampling/inductive (conjunctiva, lacrimal drainage-associated lymphoid tissue, nasal-associated lymphoid tissue, cervical lymph nodes) and effector (lacrimal gland) sites resulting in the induction of protective mucosal immune responses. Mucosal surfaces are heavily innervated with afferent nerves leading to the midbrain (lacrimatory nucleus). Cortical input (including input from the gonadal axis) also is received in the midbrain nucleus, a net signal is integrated and then sent through efferent nerves to the lacrimal glands. Cholinergic nerves, using acetylcholine (ACh) and vasoactive intestinal peptide as neurotransmitters, innervate the glands, whereas adrenergic fibers using norepinephrine go to blood vessels (not shown). The lacrimal glands contain M1 and M3 muscarinic acetylcholine receptors (mAChR) and produce secretions (tears) containing water and proteins (including S-IgA and SC) upon efferent stimulation. Sex hormones as well as various neurotransmitters and neuropeptides, via receptors on immunocytes, also influence the outcome of immune responses in the lacrimal gland.

It is now clear that the ocular surface and the LG function as a tightly integrated unit, linked by interconnecting innervation ([@bib255], [@bib256]). The surface of the eye is heavily innervated, having more afferent nerves than the combined total in the rest of the body. Also, as diagrammed in [Figure 86.3](#f3){ref-type="fig"}, conjunctival or corneal stimuli are sensed by afferent sensory neurons and the information relayed to the midbrain (lacrimatory nucleus), which also receives neural input from higher cortical regions. The net signal is "integrated" and efferent signals are sent to the blood vessels via adrenergic fibers (*i.e.,* norepinephrine as a neurotransmitter) to release water to serve as the volume for tears. A separate set of cholinergic fibers (acetylcholine and VIP as neurotransmitters) is sent to the lacrimal glands and signal acinar and ductal cells (via M3 mAChR) to pump aqueous secretion as tears ([@bib77]). The normal lacrimal gland physiology is influenced by the sex hormone milieu (regulated by the hypothalamic-pituitary-gonadal axis).

Ocular infections can influence efferent neural signaling in the lacrimal gland through induction of cholinergic enzymes, which reduce expression of acetylcholine and modulate receptors (mAChR) on acinar cells and on plasma cells, thereby decreasing fluid and immunoglobulin secretion ([@bib54]. Responses involving T lymphocyte-dependent antigens have been shown to result in production of IL-4 in lacrimal glands as well as influence cholinergic enzyme activity ([@bib249], affecting both immune processes and lacrimal physiology. Further, neuropeptides released into lymphoid structures or inflamed tissues are known to be chemotactic for antigen presenting cells and to affect their interactions with T cells ([@bib151]). Thus, it appears that consideration of the entire ocular compartment, including its connecting innervation, will be important in developing therapeutic approaches for treating dry eye conditions and vaccination strategies for eliciting protective ocular mucosal immune responses.
